LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
-4.61%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.39B
AUM Growth
-$1.8B
(-43%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-61.99%
Top 10 Holdings %
Top 10 Hldgs %
56.42%
Holding
596
New
187
Increased
52
Reduced
54
Closed
244
Top Buys
| 1 |
Warner Bros
WBD
|
+$213M |
| 2 |
Lowe's Companies
LOW
|
+$62.8M |
| 3 |
Morgan Stanley
MS
|
+$47M |
| 4 |
Citigroup
C
|
+$46M |
| 5 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$43M |
Top Sells
| 1 |
DISCA
Discovery, Inc. Series A Common Stock
DISCA
|
+$338M |
| 2 |
International Flavors & Fragrances
IFF
|
+$284M |
| 3 |
Alibaba
BABA
|
+$167M |
| 4 |
T-Mobile US
TMUS
|
+$166M |
| 5 |
Micron Technology
MU
|
+$149M |
Sector Composition
| 1 | Healthcare | 31.34% |
| 2 | Communication Services | 18.76% |
| 3 | Consumer Discretionary | 15.12% |
| 4 | Utilities | 9.34% |
| 5 | Financials | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
IonQ
IONQ
$13.1B
| $438K | 0.01% |
100,000
| – | – |
|
227
Nuvation Bio
NUVB
$1.15B
| $438K | 0.01% |
135,219
-304,547
| -69% | -$986K |
|
228
Roku
ROKU
$14.3B
| $419K | 0.01% |
5,100
+1,000
| +24% | +$82.2K |
|
229
Xilio Therapeutics
XLO
$39.6M
| $417K | 0.01% |
+142,900
| New | +$417K |
|
230
Moderna
MRNA
$9.51B
| $410K | 0.01% |
+2,871
| New | +$410K |
|
231
Kroger
KR
$44.7B
| $408K | 0.01% |
8,623
+723
| +9% | +$34.2K |
|
232
Nike
NKE
$109B
| $405K | 0.01% |
3,965
+356
| +10% | +$36.4K |
|
233
Altria Group
MO
$111B
| $403K | 0.01% |
+9,648
| New | +$403K |
|
234
Fidelity National Information Services
FIS
$35.8B
| $401K | 0.01% |
4,377
-572
| -12% | -$52.4K |
|
235
Sun Country Airlines
SNCY
$676M
| $400K | 0.01% |
+21,800
| New | +$400K |
|
236
McKesson
MCK
$87.8B
| $395K | 0.01% |
+1,212
| New | +$395K |
|
237
Agree Realty
ADC
$8B
| $354K | 0.01% |
4,901
-5,099
| -51% | -$368K |
|
238
IBM
IBM
$241B
| $353K | 0.01% |
2,501
-18,184
| -88% | -$2.57M |
|
239
Starbucks
SBUX
$95.3B
| $351K | 0.01% |
4,600
-77,655
| -94% | -$5.93M |
|
240
PNC Financial Services
PNC
$78.9B
| $346K | 0.01% |
2,190
+1,084
| +98% | +$171K |
|
241
JFrog
FROG
$5.83B
| $336K | 0.01% |
15,951
+950
| +6% | +$20K |
|
|
VIGL
242
DELISTED
Vigil Neuroscience
VIGL
| $336K | 0.01% |
+130,200
| New | +$336K |
|
243
Galecto
GLTO
$3.42M
| $330K | 0.01% |
7,626
| – | – |
|
244
Target
TGT
$41.3B
| $329K | 0.01% |
+2,330
| New | +$329K |
|
245
Applied Therapeutics
APLT
$63.4M
| $328K | 0.01% |
+345,900
| New | +$328K |
|
246
Health Care Select Sector SPDR Fund
XLV
$34.4B
| $327K | 0.01% |
+2,550
| New | +$327K |
|
247
Stellar Bancorp
STEL
$1.61B
| $315K | ﹤0.01% |
+11,859
| New | +$315K |
|
248
Industrial Select Sector SPDR Fund
XLI
$23.1B
| $306K | ﹤0.01% |
3,500
+1,300
| +59% | +$114K |
|
249
Xenon Pharmaceuticals
XENE
$2.89B
| $304K | ﹤0.01% |
+10,000
| New | +$304K |
|
250
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.8B
| $302K | ﹤0.01% |
+2,200
| New | +$302K |
|